COMMUNIQUÉS West-GlobeNewswire

Corvus Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Business Update
02/08/2018
BURLINGAME, Calif., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company focused on the development and commercialization of precisely targeted [...]
Tetraphase Pharmaceuticals Reports Second Quarter 2018 Financial Results and Recent Highlights
02/08/2018
WATERTOWN, Mass., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat life-threatening [...]
Alphatec Reports Second Quarter 2018 Financial Results
02/08/2018
CARLSBAD, Calif., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), a provider of innovative spine surgery solutions with a mission to improve patient lives through the [...]
IRIDEX Announces 2018 Second Quarter Results and Raises Full Year 2018 Guidance
02/08/2018
MOUNTAIN VIEW, Calif., Aug. 02, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the second quarter and six months ended June 30, 2018. Second Quarter Highlights Cyclo G6™ [...]
Keryx Biopharmaceuticals to Host Conference Call of Second Quarter 2018 Financial Results on Wednesday, August 8, 2018
02/08/2018
BOSTON, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, today announced that it will [...]
Marrone Bio Innovations Appoints Large Growers, Keith McGovern and Stuart Woolf, to Board of Directors
02/08/2018
Company Forms Advisory Council to Advise the Board and Management’s Strategic Vision for the Company DAVIS, Calif., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (MBI) (NASDAQ: MBII), a leading [...]
TESARO Announces Second-Quarter 2018 Operating Results
02/08/2018
ZEJULA ® Q2 net sales totaled $54 million compared to $26 million for Q2 2017 QUADRA sNDA submission planned for Q4 2018 PRIMA Phase 3 ZEJULA monotherapy trial in first-line ovarian cancer regardless of biomarker status [...]
Fluidigm Announces Second Quarter 2018 Financial Results
02/08/2018
Total revenue increases 11 percent to $26.4 million Mass cytometry revenue growth of 32 percent Total consumables revenue growth of 19 percent SOUTH SAN FRANCISCO, Calif., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Fluidigm [...]
Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call
02/08/2018
MENLO PARK, Calif., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report second quarter financial results and provide a corporate update on August 9, 2018. [...]
Ultragenyx Reports Second Quarter 2018 Financial Results and Corporate Update
02/08/2018
NOVATO, Calif, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today reported [...]
Aeterna Zentaris to Announce Second Quarter 2018 Financial and Operating Results on August 9, 2018
02/08/2018
CHARLESTON, S.C., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX: AEZS) will announce its second quarter 2018 financial and operating results after market close on Thursday, August 9, 2018. [...]
GBT Reports Recent Business Progress and Provides Second Quarter 2018 Financial Results
02/08/2018
SOUTH SAN FRANCISCO, Calif., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today reported business progress and financial results for the second quarter ended June 30, 2018. "We [...]
Zafgen Announces Departure of President and Chief Scientific Officer Dr. Thomas Hughes
02/08/2018
BOSTON, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Zafgen, Inc. , (Nasdaq:ZFGN), a clinical-stage biopharmaceutical company using its proprietary knowledge of MetAP2 systems biology to help patients affected by a range of [...]
Productive first half-year at Galapagos
02/08/2018
First half-year financial results: Group revenues of €101.9 million Operating loss of €65.8 million Net loss of €59.1 million Cash and cash equivalents on 30 June 2018 of €1,066.8 million Substantial progress in the [...]
Albireo to Report Second Quarter 2018 Financial Results, and Host Conference Call and Webcast on August 7, 2018
02/08/2018
BOSTON, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that its second quarter [...]
Adamas Reports Second Quarter 2018 Financial Results
02/08/2018
- GOCOVRI™ (amantadine) extended release capsules product sales reached $7.6 million for the second quarter - EMERYVILLE, Calif., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today [...]
T2 Biosystems Reports Second Quarter 2018 Financial Results and Provides Corporate Update
02/08/2018
Quarterly Product Revenue Up 71% Year-Over-Year Launched the Recently FDA Cleared T2Bacteria Panel, the Flagship Product in the T2Direct Diagnostics Portfolio Reiterates 2018 Financial Guidance, Including Increase to [...]
Invuity Announces 2018 Second Quarter, Six-Month Financial Results
02/08/2018
SAN FRANCISCO, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announced financial results for the second quarter and six [...]
OpGen Reports Second Quarter 2018 Financial Results And Provides Business Update
02/08/2018
Revenue increases 12% to $0.8 million, net loss narrows 21% to $3.3 million Conference call begins at 4:30 p.m. Eastern time today GAITHERSBURG, Md., Aug. 02, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today [...]

Pages